Sensorion gets go ahead to launch hearing loss gene therapy trial

The French biotechnology company Sensorion has announced that it has been given the go-ahead to launch a Phase I/II clinical trial of its gene therapy SENS-501 for gene-mediated hearing impairment in select European countries.